glp 1 fda In a major milestone for obesity care, the has approved Wegovy® as the first oral GLP-1 receptor agonist for chronic weight management in adults with obesity or overweight and related conditions FDA restricts non-approved compounded GLP-1

In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinsons disease, finds a new study led by UCL researchers.

Pendulum Metabolic Daily | Optimizes metabolism Pendulum Akkermansia | For gut health Pendulum Glucose Control | For A1C management

Mounjaro is a new medication for managing blood sugar in people with type 2 diabetes

You can learn how to file the appeals here.

See medication options, pricing, availability, microdosing, and how Josie compares.